Good practice

Good practice resources

Here we present important publications on key issues. Some items can be downloaded from the drugsandstuff website, another website, or purchased online.

Problems viewing? If you are having problems opening any PDFs, please right click the link, choose Save Target As… Then save to a location on your computer and then click Open. The PDF should now be visible. If not, you need to download a PDF viewer such as Adobe Reader.

Keep up to date

You can follow us on twitter for details of reports as and when they are released plus occasional alerts about drugsandstuff and its work.

Drugs and alcohol

Please note that these documents will open in a new window. drugsandstuff is not responsible for the content of external sites.

For the latest Government policy documents on reducing drugs misuse and dependence please see the Government’s Alcohol and Drugs Policy page.

NBOMe compounds report
NBOMe compounds: a review of the evidence of use and harm (ACMD) 2014
This paper reviews the evidence of misuse and harm in relation to the NBOMe compounds (‘novel highly potent hallucinogens’), which has been considered by ACMD at meetings of the Novel Psychoactive Substances Committee in April 2013 and by the full Council in May and October 2013.

Second report_of_the Recovery Committee
ACMD Recovery Committee: second report, November 2013
This second report from the Recovery Committee of the ACMD explores what recovery outcomes the evidence tells us we can expect from drug and alcohol dependence. It builds on their first report, ‘Recovery from drug and alcohol dependence: an overview of the evidence’, which looked at evidence around the topic of recovery.

Benzofurans: a review of the evidence of use and harmBenzofurans: A review of the evidence of use and harm (ACMD) 2013.
This report reviews the evidence of misuse and harm in relation to the benzofuran-type substances. The evidence concerning these substances and closely related analogues was considered by the ACMD at meetings of the Novel Psychoactive Substances Committee and by the full Council in 2012 and 2013. A Temporary Class Drug Order (TCDO) for these substances and some closely related analogues came into force on 10 June 2013.

ACMD Ketamine report Dec13Ketamine report (ACMD) 2013.
This report details the harms associated with the misuse of ketamine, an anaesthetic and analgesic.

The ACMD recommends that ketamine be controlled under the Misuse of Drugs Act 1971 as a Class B substance and that it is placed in Schedule II of the Misuse of Drugs Regulations 2001.

ACMD Recovery from drug or alcohol dependenceACMD – Recovery from drug and alcohol dependence: an overview of the evidence (2012).
The ACMD Recovery Committee’s first report on factors contributing to recovery from drug or alcohol dependence.

Drugs Breaking the CycleDrugs: Breaking the Cycle, Home Affairs Committee 2012.
“The last time the Home Affairs Committee looked at drug policy as a whole was in 2002, though more recent inquiries have touched on specific aspects of drug policy. We decided it would be appropriate to look again at this whole matter, and see what significant changes, if any, have taken place here and in other countries since then. As part of this inquiry, we asked the House of Commons Library to produce a note, which is appended to this Report, examining the implementation of the recommendations from the 2002 report.”

Drug strategy 2010Drug Strategy 2010 – ‘Reducing demand, restricting supply, building recovery: supporting people to live a drug-free life’ Home Office, UK. Dec 2010.
This strategy sets out the Government’s approach to tackling drugs and addressing alcohol dependence, both of which are key causes of societal harm, including crime, family breakdown and poverty.

Impact assessment for the drug strategy 2010Impact assessment
This document provides an overarching assessment of the impacts of the new drug strategy Home Office, UK – Dec 2010.

Drugs protecting families and communities 2008Drugs: protecting families and communities – 2008-2018 strategy, 2008. (PDF 1 MB).
The drug strategy aims to reduce the harm that drugs cause to society, to communities, individuals and their families. The 2008-2018 drug strategy comprises four strands of work: protecting communities through tackling drug supply, drug-related crime and anti-social behaviour, preventing harm to children, young people and families affected by drug misuse, delivering new approaches to drug treatment and social re-integration, public information campaigns, communications and community engagement.

ACMD Cannabis report, 2008Cannabis: classification and public health, 2008.
In July 2007 the Home Secretary requested, in the light of “real public concern about the potential mental health effects of cannabis use, in particular the use of stronger forms of the drug, commonly known as skunk”, that the ACMD re-assess the classification of cannabis. This report represents the council’s response to the Home Secretary’s request, giving the reasons for the majority decision by the Advisory Council on the Misuse of Drugs (ACMD) against reclassification.

Safe, Sensible, Social. The next steps in the National Alcohol StrategySafe, Sensible, Social – the next steps in the National Alcohol Strategy. UK. Home office, 2007.
In June 2007, the Department of Health and the Home Office jointly launched an updated government alcohol strategy, setting out clear goals and actions to promote sensible drinking and reduce the harm that alcohol can cause.
The strategy sets out to: minimise the health harms, violence and antisocial behaviour associated with alcohol, while ensuring that people are able to enjoy alcohol safely and responsibly.

Hidden Harm
Hidden Harm: Executive Summary 2003 (PDF 703KB)
This publication is a summary of an inquiry carried out by the Advisory Council on the Misuse of Drugs, focusing on children in the UK with a parent, parents or other guardian whose drug use has serious negative consequences for themselves and those around them.

European policy

EU Drugs Strategy 2013-2020 (PDF)

Annual report on the state of the drugs problem in Europe- EMCDDA 2012.

Harm reduction- country overviews 2012

National Drug Strategies for European Union countries EMCDDA.

More documents may be added in the coming weeks.
If you’d like to suggest a document , please get in touch